Neurocrine Bioscience buy Oppenheimer Holdings Inc.
Start price
02.08.24
/
50%
€140.30
Target price
02.08.25
€200.69
Performance (%)
-21.03%
End price
03.08.25
€110.80
Summary
This prediction ended on 03.08.25 with a price of €110.80. The prediction for Neurocrine Bioscience disappointed with a performance of -21.03%. Oppenheimer_Holdings has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Neurocrine Bioscience | -2.546% | -2.546% | 7.785% |
| iShares Core DAX® | 0.734% | 1.458% | 17.980% |
| iShares Nasdaq 100 | -2.686% | -0.146% | 3.810% |
| iShares Nikkei 225® | -2.261% | -2.729% | 11.679% |
| iShares S&P 500 | -1.346% | 0.467% | 1.970% |
Comments by Oppenheimer_Holdings for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its price target raised by analysts at Oppenheimer Holdings Inc. from $216.00 to $219.00. They now have an "outperform" rating on the stock.
Ratings data for NBIX provided by MarketBeat
In the thread Trading Neurocrine Bioscience
Die von Oppenheimer_Holdings gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Oppenheimer_Holdings for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€133.55
02.05.24
02.05.24
€201.87
02.05.25
02.05.25
-27.32%
03.05.25
03.05.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€134.95
24.04.24
24.04.24
€187.12
24.04.25
24.04.25
-29.44%
25.04.25
25.04.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€128.35
18.03.24
18.03.24
€183.92
18.03.25
18.03.25
-21.39%
19.03.25
19.03.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€94.60
02.08.23
02.08.23
€137.10
02.08.24
02.08.24
47.73%
03.08.24
03.08.24